XB2001

· XBiotech, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for XB2001, covering 2025-02-28 to 2026-08-04. Get the full timeline:

Most recent: Clinical Trial Results: XB2001 in Combination With ONIVYDE + 5-FU/LV (+Folinic Acid) in Advanced Pancreatic Cancer [Phase 1, Phase 2]